If you have already registered, please check your email for the webinar link.

Event Overview

Since Sir. Martin Evans’ 1981 identification of embryonic stem cells in mice, stem cells have been at the center of the drive to revolutionize medicine and the drug discovery process. In 1998, human embryonic stem cells were grown in a lab, and the field was further boosted in 2006 with the pivotal discovery of induced pluripotent stem (iPS) cell techniques, which removed the need to destroy embryos. But stem cell research has not come without hurdles and controversy. How far has research come since the first groundbreaking reports were published? For further insight into ongoing challenges in the stem cell arena, the mechanisms and roadblocks encountered in iPS cell technology, and the grand opportunity stem cells represent, The Scientist is bringing together a panel of experts who will share their research, explore cellular reprogramming, and discuss the next steps.

Topics to be Covered
  • Molecular mechanism of induced pluripotency
  • Roadblocks to iPSC reprogramming, and erasing transcriptional memory in cellular reprogramming
Wednesday, November 14, 2018
2:30 - 4:00 PM Eastern Time


michelle bradac.png
Matthias Stadtfeld, PhD
Assistant Professor
Skirball Institute of Biomolecular Medicine
New York University School of Medicine

michelle bradac.png
Kejin Hu, PhD, MPH
Assistant Professor
UAB Stem Cell Institute
Department of Biochemistry & Molecular Genetics
University of Alabama at Birmingham

horizon all white.jpg

horizon all white.jpg

horizon all white.jpg

Register Now

Already Registered?

Stem Cells: Opportunities, Hurdles and Promises

You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this webinar. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.